STOCK TITAN
  1. Home
  2. Sec-filings
  3. CBIO
  4. [EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing

[EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 15, 2026 4:30 P.M.
Form: S-1
CIK: 0001253689
Company Name: CRESCENT BIOPHARMA, INC.
File Number: 333-292600

Source: View Original Filing on SEC EDGAR

Crescent Biopharma Inc

NASDAQ:CBIO

View CBIO Stock Overview →

CBIO Rankings

#3652 Ranked by Market Cap
N/A Ranked by Dividends

CBIO Latest News

Mar 27, 2026
Crescent Biopharma Announces Grants of Inducement Awards
Mar 6, 2026
Crescent Biopharma Announces Grants of Inducement Awards
Feb 26, 2026
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Feb 23, 2026
Crescent Biopharma to Present at March Investor Conferences
Feb 19, 2026
Crescent Biopharma Announces Grants of Inducement Awards

CBIO Latest SEC Filings

Mar 17, 2026
[424B3] CRESCENT BIOPHARMA, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 2, 2026
[POS AM] CRESCENT BIOPHARMA, INC. SEC Filing
Feb 26, 2026
[424B3] CRESCENT BIOPHARMA, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Feb 26, 2026
[8-K] CRESCENT BIOPHARMA, INC. Reports Material Event
Feb 26, 2026
[10-K] CRESCENT BIOPHARMA, INC. Files Annual Report

CBIO Stock Data

411.03M
25.40M
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM